Attacking COVID-19 Progression Using Multi-Drug Therapy for Synergetic Target Engagement
COVID-19 is a devastating respiratory and inflammatory illness caused by a new coronavirus that is rapidly spreading throughout the human population. Over the past 12 months, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for COVID-19, has already infected over 1...
Main Authors: | Mathew A. Coban, Juliet Morrison, Sushila Maharjan, David Hyram Hernandez Medina, Wanlu Li, Yu Shrike Zhang, William D. Freeman, Evette S. Radisky, Karine G. Le Roch, Carla M. Weisend, Hideki Ebihara, Thomas R. Caulfield |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/11/6/787 |
Similar Items
-
3D Bioprinting for Next-Generation Personalized Medicine
by: Ethan Hau Yin Lam, et al.
Published: (2023-03-01) -
Emerging trends in organ-on-a-chip systems for drug screening
by: Yanping Wang, et al.
Published: (2023-06-01) -
Fragment-Based Drug Discovery against Mycobacteria: The Success and Challenges
by: Namdev S. Togre, et al.
Published: (2022-09-01) -
Emerging toolset of three-dimensional pulmonary cell culture models for simulating lung pathophysiology towards mechanistic elucidation and therapeutic treatment of SARS-COV-2 infection
by: Kai Ni, et al.
Published: (2022-12-01) -
Digital light processing (DLP)‐based (bio)printing strategies for tissue modeling and regeneration
by: Hongbin Li, et al.
Published: (2023-04-01)